Shu Ishida

Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy [RETRACTED]

Yoshihiro Satō, Izumi Kondo, Shu Ishida et al. · Neurology · 2001 · 275 citations

Medicine, Pharmacology, Pharmacotherapy +17

SH3BP2 Cherubism Mutation Potentiates TNF-α–Induced Osteoclastogenesis via NFATc1 and TNF-α–Mediated Inflammatory Bone Loss

Tomoyuki Mukai, Shu Ishida, Remi Ishikawa et al. · Journal of Bone and Mineral Research · 2014 · 62 citations · Full text

Medicine, Molecular Genetics, Pathobiology +17

Loss of SH3 Domain–Binding Protein 2 Function Suppresses Bone Destruction in Tumor Necrosis Factor–Driven and Collagen‐Induced Arthritis in Mice

Tomoyuki Mukai, Richard Gallant, Shu Ishida et al. · Arthritis & Rheumatology · 2014 · 50 citations · Full text

Medicine, Immunology, Pathobiology +12

Enhanced TLR-MYD88 Signaling Stimulates Autoinflammation in SH3BP2 Cherubism Mice and Defines the Etiology of Cherubism

Teruhito Yoshitaka, Tomoyuki Mukai, Mizuho Kittaka et al. · Cell Reports · 2014 · 48 citations · Full text

Life Sciences, Immunology, Pathology +17

A pilot study of dehydroepiandrosterone sulfate in myotonic dystrophy

Megumi Sugino, N Ohsawa, Tomotaka Ito et al. · Neurology · 1998 · 48 citations

Medicine, Neurology, Pharmacotherapy +10